Article Information
History
- March 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Guillermo Bosch, MD1,2,
- Margarita Posso, MD, PhD1,3,*,
- Javier Louro, PhD1,3,
- Marta Roman, PhD1,3,
- Miquel Porta, MD, PhD4,5,6,
- Xavier Castells, MD, PhD1,3,4 and
- Francesc Macià, MD1,3
- 1Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
- 2Preventive Medicine and Public Health Training Unit PSMar-ASPB-UPF, Barcelona, Spain
- 3Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Barcelona, Spain
- 4Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
- 5Hospital del Mar Institute of Medical Research (IMIM PSMar), Barcelona, Catalonia, Spain
- 6Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain
- ↵*Corresponding author
Margarita Posso, MD, PhD, Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Maritím 25-29, 08003, Barcelona, Spain. E-mail: mposso{at}parcdesalutmar.cat, Telephone number: +34 932483929
Posted March 07, 2022.
Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study
